trial
random
observerblind
parallel
group
multicountri
trial
vs
nonadjuv
monoval
pandem
vaccin
trial
conduct
center
australia
brazil
colombia
costa
rica
mexico
philippin
singapor
thailand
februari
august
complet
enrol
took
month
vari
countri
institut
review
board
particip
center
approv
trial
parentsguardian
provid
written
inform
consent
healthi
children
age
month
year
enrol
passiv
surveil
conduct
day
first
vaccin
parent
instruct
contact
studi
center
within
hour
child
becam
ill
activ
surveil
via
script
telephon
contact
conduct
week
first
vaccin
contact
made
everi
week
day
ili
defin
fever
temperatur
rout
least
follow
newworsen
cough
sore
throat
nasal
congest
rhinorrhea
one
anterior
nasal
swab
throat
swab
collect
ideal
within
hour
ili
onset
within
day
swab
transport
singl
tube
transport
medium
store
maintain
dri
ice
transport
sampl
ideal
collect
child
home
visit
studi
center
could
arrang
necessari
child
hospit
sampl
collect
hospit
feasibl
symptomfre
period
requir
new
ili
episod
analysi
sampl
rsv
subtyp
b
respiratori
pathogen
perform
use
standard
multiplex
polymeras
chain
reaction
pcr
techniqu
primari
outcom
variabl
pcrconfirm
rsv
nasalthroat
swab
children
ili
primari
outcom
includ
singl
rsv
infect
coinfect
respiratori
virus
singl
rsv
infect
coinfect
respiratori
virus
also
record
separ
pneumonia
document
children
ili
defin
acut
ill
follow
symptom
fever
temperatur
new
worsen
cough
dyspnea
consist
auscult
find
rale
diminish
breath
sound
pain
chest
abdomen
breath
purul
bloodstain
sputum
product
radiolog
find
consist
pneumonia
clinic
characterist
ili
episod
report
child
parent
medic
attend
hospit
record
medic
attend
includ
contact
studi
personnel
collect
nasalthroat
sampl
analysi
preval
perform
total
cohort
ili
episod
test
multiplex
pcr
includ
children
enrol
experienc
ili
adequ
nasalthroat
sampl
preval
rsv
respiratori
virus
among
ili
episod
calcul
follow
preval
xn
x
number
ili
episod
nasalthroat
sampl
posit
viru
n
total
number
ili
episod
sampl
collect
within
day
test
window
least
day
ili
episod
assum
episod
independ
exact
confid
interv
ci
comput
preval
stratifi
accord
countri
age
time
ili
episod
month
whether
child
medic
attend
saw
doctor
healthcar
profession
whether
child
hospit
analysi
incid
perform
total
cohort
includ
children
enrol
incid
per
personyear
py
rsvassoci
ili
studi
popul
calcul
follow
incid
rate
n
total
number
children
enrol
total
number
rsvposit
ili
episod
subject
followup
period
subject
incid
rate
stratifi
accord
countri
age
group
time
ili
episod
exact
poisson
ci
calcul
observ
incomplet
data
outcom
variabl
ili
episod
nasalthroat
sampl
taken
remov
analysi
miss
data
account
use
analysi
wherebi
miss
proport
countri
age
group
calcul
py
multipli
minu
miss
proport
rsv
subtyp
b
detect
ili
episod
overal
preval
ci
tabl
episod
associ
infect
rsv
rsv
plu
coinfect
anoth
respiratori
viru
es
commonli
rhinovirusenteroviru
supplementari
tabl
preval
rsv
ili
rang
costa
rica
philippin
australia
tabl
figur
overal
preval
rsv
ili
declin
age
tabl
figur
howev
philippin
countri
preval
highest
age
group
countri
highest
preval
age
group
children
age
month
australia
colombia
costa
rica
singapor
thailand
experienc
ili
episod
associ
rsv
infect
preval
brazil
mexico
respect
overal
preval
rsv
subtyp
among
ili
episod
vari
countri
age
supplementari
tabl
across
age
group
highest
australia
lowest
costa
rica
across
countri
highest
age
group
lowest
age
group
overal
preval
rsv
subtyp
b
among
ili
episod
also
variabl
countri
age
supplementari
tabl
across
age
group
highest
philippin
lowest
mexico
across
countri
highest
age
group
lowest
age
group
overal
incid
rsvassoci
ili
studi
popul
ci
per
py
highest
incid
occur
children
age
month
countri
except
philippin
incid
highest
youngest
age
group
mexico
similar
children
age
month
tabl
philippin
highest
incid
rsvassoci
ili
per
py
follow
brazil
singapor
australia
per
py
lower
incid
record
colombia
costa
rica
mexico
thailand
per
py
occurr
rsv
differ
time
year
highli
variabl
across
countri
figur
total
ili
episod
result
hospit
associ
rsv
ci
preval
among
nonhospit
episod
similar
ci
overal
incid
rsvassoci
ili
hospit
ci
per
py
pattern
hospit
across
age
group
countri
observ
supplementari
tabl
median
hospit
stay
episod
day
rang
day
three
hospit
occur
children
rsv
coinfect
anoth
respiratori
pathogen
stay
day
thailand
day
thailand
day
colombia
remain
hospit
associ
rsv
infect
alon
stay
day
philippin
day
colombia
day
costa
rica
day
mexico
day
mexico
among
ili
episod
medic
attend
rsv
preval
ci
rsv
preval
among
nonmed
attend
ili
episod
ci
overal
incid
rsvassoci
ili
result
medic
attend
ci
per
py
pattern
across
age
group
countri
observ
tabl
among
rsvassoci
ili
episod
medic
attend
similar
regardless
whether
children
infect
rsv
alon
coinfect
rsv
anoth
respiratori
pathogen
children
ili
associ
rsv
experienc
fever
part
ili
case
definit
experienc
runni
nose
total
children
experienc
sore
throat
experienc
stuffi
nose
almost
children
ili
associ
rsv
experienc
new
worsen
cough
common
symptom
lower
respiratori
tract
infect
among
children
ili
rsv
infect
experienc
new
worsen
cough
median
length
ili
episod
associ
rsv
day
median
differ
age
group
rang
day
australia
day
brazil
day
colombia
day
costa
rica
day
mexico
day
philippin
day
singapor
day
thailand
total
rsvassoci
episod
result
absenc
school
day
care
median
day
miss
median
differ
age
group
rang
day
australia
day
brazil
day
colombia
day
costa
rica
day
mexico
day
philippin
day
singapor
day
thailand
highest
number
day
miss
occur
children
age
month
countri
except
philippin
singapor
countri
children
oldest
age
group
miss
school
day
care
longest
period
occur
age
group
twenti
children
ili
experienc
pneumonia
clinic
studi
nasalthroat
sampl
collect
test
ili
episod
result
pneumonia
rsv
detect
preval
rsv
pneumonia
ci
episod
occur
colombia
associ
rsv
alon
last
day
day
hospit
colombia
associ
rsv
rhinovirusenteroviru
last
day
day
hospit
mexico
associ
rsv
alon
last
day
day
hospit
understand
rsv
epidemiolog
implement
effect
control
measur
essenti
captur
rsv
burden
commun
therefor
conduct
year
prospect
activ
passiv
communitybas
surveil
healthi
children
multipl
tropic
southern
hemispher
countri
prospect
data
lack
communitybas
surveil
difficult
costli
carri
studi
base
hospitalbas
surveil
captur
sever
rsv
infect
result
hospit
limit
develop
countri
depend
access
hospit
studi
conduct
part
clinic
trial
benefit
activ
followup
wellcharacter
popul
consist
methodolog
countri
sampl
taken
high
proport
children
use
sensit
specif
pcr
assay
rsv
detect
addit
studi
wide
age
rang
year
unlik
studi
typic
focus
children
age
year
stratifi
age
group
could
detect
differ
incid
preval
across
age
studi
show
preval
rsv
type
b
ili
rang
across
countri
overal
preval
observ
overal
preval
rsv
subtyp
b
ili
higher
subtyp
vs
although
consist
across
countri
overal
preval
declin
age
rang
age
group
age
group
philippin
countri
highest
rsv
preval
youngest
age
group
countri
highest
preval
age
group
incid
rsv
ili
across
countri
rang
per
py
month
per
py
month
per
py
month
per
py
month
per
py
month
philippin
mexico
countri
highest
incid
infant
age
month
countri
highest
incid
age
group
howev
interpret
month
estim
limit
data
spars
age
group
ili
episod
occur
among
children
age
month
time
episod
result
wide
ci
cohort
effect
also
probabl
sinc
children
left
age
group
reach
age
month
children
enter
thu
unlik
group
children
remain
age
group
approxim
month
postenrol
result
observ
period
group
shorten
estim
captur
portion
total
rsv
season
activ
surveil
studi
tend
report
higher
preval
incid
rsv
passiv
surveil
much
less
common
activ
surveil
studi
report
preval
incid
per
personyear
rsv
respiratori
diseas
avail
howev
differ
case
definit
locat
age
method
viral
detect
limit
comparison
studi
australia
activ
surveil
detect
rsv
sampl
preschool
children
acut
respiratori
infect
ari
global
systemat
review
rsvassoci
alri
children
age
year
identifi
studi
use
activ
surveil
estim
incid
per
py
studi
bangladesh
india
indonesia
kenya
nigeria
guatemala
sever
activ
surveil
studi
evalu
rsv
differ
age
group
children
indonesia
age
month
incid
rsvassoci
lower
respiratori
tract
infect
lrti
highest
children
age
month
per
py
age
group
much
lower
incid
rsvassoci
lrti
indonesia
seen
anoth
studi
although
highest
incid
age
group
indonesia
rel
low
incid
hypothes
link
cultur
practic
newborn
kept
isol
possibl
first
month
life
use
protocol
nigeria
yield
incid
rate
approxim
per
py
highest
rate
age
group
kenya
incid
rsvassoci
lrti
highest
infant
age
month
per
py
incid
per
py
children
age
month
studi
india
report
uniform
distribut
rsvassoci
alri
across
age
group
per
py
children
age
month
respect
studi
illustr
consider
burden
rsvassoci
ill
far
know
first
activ
surveil
studi
rsv
captur
incid
data
medic
attend
outsid
hospit
set
ili
episod
medic
attend
overal
incid
rsvassoci
ili
requir
medic
attend
per
py
one
third
ili
episod
associ
rsv
result
absenc
school
day
care
howev
children
attend
school
day
care
eight
ili
episod
requir
hospit
associ
rsv
overal
incid
per
py
compar
rsvassoci
lrti
hospit
per
py
kenya
howev
surprisingli
pneumonia
case
observ
studi
recent
review
pneumonia
worldwid
estim
number
new
episod
rsvassoci
pneumonia
children
age
year
australia
brazil
colombia
costa
rica
mexico
philippin
singapor
thailand
although
incid
rate
calcul
one
import
studi
limit
healthi
children
enter
efficaci
trial
eg
children
malnutrit
particip
healthier
random
commun
sampl
thu
limit
generaliz
despit
limit
demonstr
high
rsv
burden
highlight
confin
children
high
risk
fever
part
ili
definit
captur
ari
like
miss
case
associ
rsv
children
fever
put
context
fever
record
approxim
rsvposit
respiratori
tract
infect
primarili
children
age
year
month
addit
unabl
calcul
absolut
popul
denomin
rate
rsv
incid
hospit
rel
small
number
rsvassoci
ill
subanalys
final
recruit
children
age
month
limit
number
children
age
month
find
relev
older
children
use
activ
surveil
healthi
children
provid
evid
consider
burden
rsvassoci
ill
would
identifi
usual
hospitalbas
surveil
method
substanti
part
rsv
burden
occur
older
infant
children
implic
futur
vaccin
strategi
includ
possibl
broaden
target
age
rang
